New Insights into Migraine Treatment: CGRP Levels After Monoclonal Antibody Cessation
03 Jun 2024
Researchers have made some fascinating discoveries about the treatment of migraine Calcitonin gene-related peptide (CGRP) has long been...
MORE NEWS
Bertin Bioreagent is a leader in biomarker assay kit development, production and distribution for life sciences lab thanks to 30 years of expertise.
Toxicity and efficiency of new molecules and drugs can be determined by studying biomarkers. Any biomarker deserves to have its best-in-class analytical tool which should be robust, ready to use, worldwide available and approved by the scientific community.
Bertin Bioreagent offers more than 40 references of assay kits (ELISA, EIA, enzymatic…) and 240 references of antibodies (monoclonal and polyclonal) targeting biomarkers involved in various fields such as obesity, diabetes, pain, inflammation or endocrinology. Bertin can also develop custom made assay kits to find specific targets. The product range also includes necessary pre-analytical tools and biochemicals to collect and pre-treat samples for future analysis.
03 Jun 2024
Researchers have made some fascinating discoveries about the treatment of migraine Calcitonin gene-related peptide (CGRP) has long been...
17 May 2024
LEAP-2 helps regulate inflammatory responses and maintain microbiota balance Discover the high performance of LEAP-2, the new ELISA kit...
ANY QUESTIONS? CONTACT AN EXPERT
Please fill in this form if you wish to contact our sales team or receive further information.
Add a question !